TCT-37 Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Bioresorbable vascular scaffolds represent an exciting advance in percutaneous coronary intervention (PCI), providing an initial coronary scaffold which are eventually resorbed by the body. The DESolve(r) Nx Bioresorbable Coronary Scaffold System (BCSS) is a novel drug eluting bioresorbable scaffold